Qiagen N.V. (QGEN) Discusses Strategic Priorities and Latest Developments for QuantiFERON and Latent Tuberculosis Testing - Slideshow

🇺🇸 Seeking Alpha (US) —

AI Summary

Qiagen N.V. discussed its strategic priorities and recent developments concerning QuantiFERON and latent tuberculosis testing during a presentation. The company emphasized its commitment to enhancing diagnostics and expanding market presence.

Health AI & Tech Qiagen QuantiFERON latent tuberculosis diagnostics strategic priorities

Read original source →